The mechanism of action of inhibitors of DNA synthesis.
D000085:Acetates / Q000494:pharmacology; D000818:Animals; D001412:Bacillus subtilis / Q000201:enzymology; D003561:Cytarabine / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis*; D004256:DNA Polymerase I / Q000037:antagonists & inhibitors; D004257:DNA Polymerase II / Q000037:antagonists & inhibitors; D004258:DNA Polymerase III / Q000037:antagonists & inhibitors; D004261:DNA Replication / Q000187:drug effects*; D004486:Edeine / Q000494:pharmacology; D006834:Hydrazines / Q000494:pharmacology; D009268:Nalidixic Acid / Q000494:pharmacology; D009675:Novobiocin / Q000494:pharmacology; D019384:Nucleic Acid Synthesis Inhibitors; D063065:Organophosphonates / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D013329:Structure-Activity Relationship; D014740:Vidarabine / Q000494:pharmacology; D009353:Zinostatin / Q000494:pharmacology
D000085:Acetates; D006834:Hydrazines; D019384:Nucleic Acid Synthesis Inhibitors; D063065:Organophosphonates; D011743:Pyrimidines; D003561:Cytarabine; D004486:Edeine; D009675:Novobiocin; D009268:Nalidixic Acid; D004247:DNA; D009353:Zinostatin; D004256:DNA Polymerase I; D004257:DNA Polymerase II; D004258:DNA Polymerase III; D014740:Vidarabine